Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma
========================================================================================================================================================================================

* Walter J Storkus
* Deena Maurer
* Yan Lin
* Fei Ding
* Anamika Bose
* Devin Lowe
* Amy Rose
* Melissa DeMark
* Lilit Karapetyan
* Jennifer L Taylor
* Manoj Chelvanambi
* Ronald J Fecek
* Jessica N Filderman
* Timothy J Looney
* Lauren Miller
* Elizabeth Linch
* Geoffrey M Lowman
* Pawel Kalinski
* Lisa H Butterfield
* Ahmad Tarhini
* Hussein Tawbi
* John M Kirkwood